DarkPulse (DPLS) 10-Q 16 Nov 20 2021 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 10, 2020
Cover [Abstract]
Entity Registrant Name	DarkPulse, Inc.
Entity Central Index Key	0000866439
Document Type	10-Q
Document Period End Date	Sep. 30, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		4,088,762,156
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Entity Small Business	true
Entity Emerging Growth	false
Entity Shell Company	false
Entity Incorporation State	DE
Entity File Number	000-18730
Entity Interactive data	Yes

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
CURRENT ASSETS:
Cash	$ 519	$ 1,210
Prepaid expenses	746	746
Total current assets	1,265	1,956
Other assets, net	121,464	116,495
Patents, net	406,747	445,018
Total assets	529,476	563,469
CURRENT LIABILITIES:
Accounts payable	498,887	323,948
Convertible notes, net of discount 0 and $39,414 respectively	944,306	1,033,249
Derivative liability	1,320,184	1,275,500
Accrued Liabilities	588,693	497,078
Contract liability, related party	42,000	42,000
Related party notes payable	44,096	44,096
Total current liabilities	3,438,166	3,215,871
Secured Debenture	1,141,494	1,155,150
Total liabilities	4,579,660	4,371,021
Commitments and contingencies
STOCKHOLDERS' DEFICIT
Common stock (par value $0.01), 20,000,000,000 shares authorized, 3,394,817,156 and 1,392,042,112 shares issued and outstanding respectively	33,948,172	13,920,421
Treasury stock, 100,000 shares	(1,000)	(1,000)
Convertible preferred stock, Series D (par value $0.01) 100,000 shares authorized, 88,235 shares issued and outstanding respectively	883	883
Paid-in capital in excess of par value	(31,773,340)	(11,877,864)
Non-controlling interest in a variable interest entity and subsidiary	(12,439)	(12,439)
Accumulated other comprehensive income	350,429	336,775
Accumulated deficit	(6,562,889)	(6,174,328)
TOTAL STOCKHOLDERS' DEFICIT	(4,050,184)	(3,807,552)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 529,476	$ 563,469

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Convertible Notes, discount	$ 0	$ 39,414
Convertible preferred stock - shares authorized	2,000,000	2,000,000
Common stock par value (in Dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	20,000,000,000	20,000,000,000
Common stock, shares issued	3,394,817,156	1,392,042,112
Common stock, shares outstanding	3,394,817,156	1,392,042,112
Treasury stock shares	100,000	100,000
Class D Voting Preferred Stock [Member]
Convertible preferred stock - par value	$ 0.01	$ 0.01
Convertible preferred stock - shares authorized	100,000	100,000
Convertible preferred stock - shares issued	88,235	88,235
Convertible preferred stock - shares outstanding	88,235	88,235

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Revenues	$ 0	$ 0	$ 0	$ 0
OPERATING EXPENSES:
General and administrative expenses	34,782	40,453	120,866	144,965
Payroll and compensation	0	0	187	168,945
Legal expenses	0	48,868	48,297	96,962
Amortization of patents	12,757	12,757	38,271	38,271
Debt transaction expenses	0	0	0	24,900
Total operating expenses	47,539	102,078	207,621	474,043
OPERATING LOSS	(47,539)	(102,078)	(207,621)	(474,043)
OTHER INCOME (EXPENSE):
Interest expense	(37,318)	(50,649)	(97,842)	(399,895)
Loss on convertible notes	(1,313)	(47,266)	(39,414)	(351,662)
Gain on the forgiveness of debt	0	0	1,000	0
Gain (Loss) on change in fair market values of derivative liabilities	(87,852)	221,879	(44,684)	566,127
TOTAL OTHER INCOME (EXPENSE)	(126,483)	123,964	(180,940)	(185,430)
NET INCOME (LOSS)	(174,022)	21,866	(388,561)	(659,473)
Net Loss attributable to noncontrolling interests in variable interest entity and subsidiary	0	0	0	0
Net loss attributable to Company stockholders	$ (174,022)	$ 21,866	$ (388,561)	$ (659,473)
GAIN (LOSS) PER SHARE:
Basic and Diluted	$ 0	$ 0	$ 0	$ 0
WEIGHTED AVERAGE SHARES OUTSTANDING:
Basic and Diluted	2,355,108,904	518,604,087	1,754,933,152	252,457,517

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Gain/Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
NET LOSS	$ (174,022)	$ 21,866	$ (388,561)	$ (659,473)
OTHER COMPREHENSIVE INCOME (LOSS)
Unrealized Gain (Loss) on Foreign Exchange	(39,046)	12,671	13,656	(30,722)
COMPREHENSIVE INCOME (LOSS)	$ (213,967)	$ 34,557	$ (374,905)	$ (690,195)

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Deficit (Equity) (Unaudited) - USD ($)	Preferred Stock	Common Stock	Treasury Stock	Additional Paid-In Capital	Noncontrolling Interest	Accumulated Other Comprehensive Income	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2018	88,235	89,680,467
Beginning balance, value at Dec. 31, 2018	$ 883	$ 896,806	$ (1,000)	$ 859,481	$ (12,439)	$ 389,680	$ (4,348,859)	$ (2,215,448)
Conversion of convertible notes, shares		12,488,347
Conversion of convertible notes, value		$ 124,883		(45,837)				79,046
Foreign currency adjustment						(22,050)		(22,050)
Net loss							(806,568)	(806,568)
Ending balance, shares at Mar. 31, 2019	88,235	102,168,914
Ending balance, value at Mar. 31, 2019	$ 883	$ 1,021,689	(1,000)	813,644	(12,439)	367,630	(5,155,427)	(2,965,020)
Conversion of convertible notes, shares		137,005,692
Conversion of convertible notes, value		$ 1,370,057		(1,284,135)				85,922
Foreign currency adjustment						(21,343)		(21,343)
Net loss							125,210	125,210
Ending balance, shares at Jun. 30, 2019	88,235	239,174,606
Ending balance, value at Jun. 30, 2019	$ 883	$ 2,391,746	(1,000)	(471,491)	(12,439)	346,287	(5,030,217)	(2,775,231)
Conversion of convertible notes, shares		137,005,692
Conversion of convertible notes, value		$ 1,370,057		(1,284,135)				85,922
Foreign currency adjustment						12,671		12,671
Net loss							21,886	21,886
Ending balance, shares at Sep. 30, 2019	88,235	239,174,606
Ending balance, value at Sep. 30, 2019	$ 883	$ 2,391,746	(1,000)	(471,491)	(12,439)	358,958	(5,008,332)	(2,642,069)
Beginning balance, shares at Dec. 31, 2019	88,235	1,392,042,112
Beginning balance, value at Dec. 31, 2019	$ 883	$ 13,920,421	(1,000)	(11,877,864)	(12,439)	336,775	(6,174,328)	(3,807,552)
Foreign currency adjustment						92,646		92,646
Net loss							(74,298)	(74,298)
Ending balance, shares at Mar. 31, 2020	88,235	1,392,042,112
Ending balance, value at Mar. 31, 2020	$ 883	$ 13,920,421	(1,000)	(11,877,864)	(12,439)	429,421	(6,248,626)	(3,789,204)
Conversion of convertible notes, shares		217,142,858
Conversion of convertible notes, value		$ 2,171,429		(2,156,228)				15,201
Foreign currency adjustment						(39,047)		(39,047)
Net loss							(140,241)	(140,241)
Ending balance, shares at Jun. 30, 2020	88,235	1,609,184,970
Ending balance, value at Jun. 30, 2020	$ 883	$ 16,091,850	(1,000)	(14,034,092)	(12,439)	390,374	(6,388,867)	(3,953,291)
Conversion of convertible notes, shares		1,785,632,186
Conversion of convertible notes, value		$ 17,856,322		(17,739,248)				117,074
Foreign currency adjustment						(39,945)		(39,945)
Net loss							(174,022)	(174,022)
Ending balance, shares at Sep. 30, 2020	88,235	3,394,817,156
Ending balance, value at Sep. 30, 2020	$ 883	$ 33,948,172	$ (1,000)	$ (31,773,340)	$ (12,439)	$ 350,429	$ (6,562,889)	$ (4,050,184)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Gain/(Loss)	$ (388,561)	$ (659,473)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization	38,271	38,271
Loan acquisition costs	0	24,900
Gain on reduction of loan default penalty	(9,900)	0
Interest on notes payable	0	27,446
Debt discount		(205,000)
Amortization of debt discount	39,414	568,985
Derivative liability	44,684	(312,622)
Changes in operating assets and liabilities:
Accounts payable	174,935	205,025
Accrued Liabilities	105,435	110,340
Net cash used in operating activities	4,278	(202,128)
CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in patents	(4,969)	(54,930)
Net cash used by investing activities	(4,969)	(54,930)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible notes payable	0	180,100
Payments on convertible notes	0	(24,650)
Net cash provided by financing activities	0	155,450
NET INCREASE (DECREASE) IN CASH	(691)	(70,886)
CASH, beginning of period	1,210	72,294
CASH, end of period	519	1,408
Noncash investing and financing activities for the quarter ending
Stock issued for convertible notes payable and accrued interest	132,276	232,535
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid in cash	0	0
Taxes paid in cash	$ 0	$ 0

1. BASIS OF FINANCIAL STATEMENT

1. BASIS OF FINANCIAL STATEMENT PRESENTATION	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF FINANCIAL STATEMENT PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 – BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial statements and do not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The information furnished reflects all adjustments, consisting only of normal recurring items which are, in the opinion of management, necessary in order to make the financial statements not misleading. The consolidated financial statements as of December 31, 2019 have been audited by an independent registered public accounting firm. The accounting policies and procedures employed in the preparation of these condensed consolidated financial statements have been derived from the audited financial statements of the Company for the year ended December 31, 2019, which are contained in Form 10-K as filed with the Securities and Exchange Commission on June 8, 2020. The consolidated balance sheet as of December 31, 2019 was derived from those financial statements. Basis of Presentation and Principles of Consolidation The consolidated financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles of the United States of America (“U.S. GAAP”) and the rules and regulations of the U.S Securities and Exchange Commission for Interim Financial Information. The condensed consolidated financial statements of the Company include the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated. All adjustments (consisting of normal recurring items) necessary to present fairly the Company’s financial position as of September 30, 2020, and the results of operations for three and nine months and cash flows for the nine months ended September 30, 2020 have been included. The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year. Description of Business DarkPulse, Inc. ("DPI" or "Company") is a technology-security company incorporated in 1989 as Klever Marketing, Inc. ("Klever"). The Company’s wholly-owned subsidiary, DarkPulse Technologies Inc. ("DPTI"), originally started as a technology spinout from the University of New Brunswick (the “University”) located in Fredericton, Canada. The Company’s security and monitoring systems will initially be delivered in applications for border security, pipelines, the oil and gas industry and mine safety. Current uses of fiber optic distributed sensor technology have been limited to quasi-static, long-term structural health monitoring due to the time required to obtain the data and its poor precision. On April 27, 2018, Klever entered into an Agreement and Plan of Merger (the “Merger Agreement” or the “Merger”) involving Klever as the surviving parent corporation and acquiring a privately held New Brunswick corporation known as DarkPulse Technologies Inc. as its wholly owned subsidiary. On July 18, 2018, the parties closed the Merger Agreement, as amended on July 7, 2018, and the name of the Company was subsequently changed to DarkPulse, Inc. With the change of control of the Company, the Merger was accounted for as a recapitalization in a manner similar to a reverse acquisition. On July 20, 2018, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the State of Delaware, changing the name of the Company to DarkPulse, Inc. The Company filed a corporate action notification with the Financial Industry Regulatory Authority (FINRA), and the Company's ticker symbol was changed to DPLS. Going Concern Uncertainty As shown in the accompanying financial statements, during the nine months ended September 30, 2020, the Company did not generate any revenues and reported a net loss of $214,539. As of September 30, 2020, the Company’s current liabilities exceeded its current assets by $3,436,901. As of September 30, 2020, the Company had $519 of cash. The Company will require additional funding during the next nine months to finance the growth of its operations and achieve its strategic objectives. These factors, as well as the uncertain conditions that the Company faces relative to capital raising activities, create substantial doubt as to the Company’s ability to continue as a going concern. The Company is seeking to raise additional capital principally through private placement offerings and is targeting strategic partners in an effort to finalize the development of its products and begin generating revenues. The ability of the Company to continue as a going concern is dependent upon the success of future capital offerings or alternative financing arrangements and expansion of its operations. The accompanying financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. Management is actively pursuing additional sources of financing sufficient to generate enough cash flow to fund its operations. However, management cannot make any assurances that such financing will be secured. Use of Estimates In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the statements of financial condition, and revenues and expenses for the years then ended. Actual results may differ significantly from those estimates. Significant estimates made by management include, but are not limited to, the assumptions used to calculate stock-based compensation, derivative liabilities, preferred deemed dividend and common stock issued for services. Cash and Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less when acquired to be cash equivalents. The Company places its cash with a high credit quality financial institution. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits. Intangible Assets The Company reviews intangibles held and used for possible impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In evaluating the fair value and future benefits of its intangible assets, management performs an analysis of the anticipated undiscounted future net cash flow of the individual assets over the remaining amortization period. The Company recognizes an impairment loss if the carrying value of the asset exceeds the expected future cash flows. Foreign Currency Translation The company translates monetary assets and liabilities (any item paid for or settled in foreign currency) into the United States Dollar at exchange rates prevailing on the balance sheet date. Non-monetary assets and liabilities are translated at the historical rate in effect when the transaction occurred. Revenues and expenses are translated at the spot rate on the date the transaction occurred. Exchange gains and losses from the translation of monetary items are included in unrealized gain/loss on Foreign Exchange as Other Comprehensive Loss. The following table discloses the dates and exchange rates used for converting Canadian Dollar amounts to U.S. Dollar amounts disclosed in the balance sheet and the statement of operations. The spot exchange rate between the Canadian Dollar and the U.S. Dollar on, December 31, 2019 closing rate at 1.2988 US$: CAD, average rate at 1.3234 US$: CAD and for the three months ended September 30, 2020 closing rate at 1.3141 US$: CAD, average rate at 1.3340 US$. Income Taxes The Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes, as clarified by ASC 740-10, Accounting for Uncertainty in Income Taxes. Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which the Company operates, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the "more likely than not" criteria of ASC 740. ASC 740-10 requires that the Company recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the "more-likely-than-not" threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Fair Value of Financial Instruments The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, and accruals approximate their fair values because of the short maturity of these instruments. The Company believes the carrying value of its secured debenture payable approximates fair value because the terms were negotiated at arm’s length. Recent Accounting Pronouncements There were no new accounting pronouncements issued or proposed by the Financial Accounting Standards Board during the three months ended September 30, 2020, and through the date of filing of this report that the Company believes has had or will have a material impact on its financial position or results of operations, including the recognition of revenue, cash flow, the merger that was consummated on July 18, 2018. The Company has no lease obligations. Income (Loss) Per Common Share Basic net income (loss) per share of common stock is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share of common stock is computed by dividing net income (loss) by the sum of the weighted average number of common shares outstanding and the dilutive potential common share equivalents outstanding. Potential dilutive common share equivalents consist of shares issuable upon exercise of outstanding convertible preferred stock and stock options. For the three and nine months ended September 30, 2020, there were no stock options nor convertible preferred stock outstanding. For the three and nine months ended September 30, 2020, common stock equivalents related to convertible preferred stock and convertible debt have not been included in the calculation of diluted loss per common share because they are anti-dilutive. Therefore, basic loss per common share is the same as diluted loss per common share. There are 2,138,539,986 common shares reserved for the potential conversion of the Company's convertible debt.

2. DEBENTURE

2. DEBENTURE	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Debenture	NOTE 2 - DEBENTURE DPTI issued a convertible debenture to the University in exchange for the patents (the “Patents”) assigned to the Company, in the amount of CAD$1,500,000, or USD$1,491,923 on December 16, 2010, the date of the convertible debenture. On April 24, 2017 DPTI issued a replacement secured term convertible debenture (the “Debenture”) in the same CAD$1,500,000 amount as the original convertible debenture. The interest rate is the Bank of Canada Prime overnight rate plus 1% per annum. The Debenture had an initial required payment of CAD $42,000 (USD$33,385) due on April 24, 2018 for reimbursement to the University for its research and development costs, and this has been paid. Interest-only maintenance payments are due annually starting after April 24, 2018. Payment of the principal begins on the earlier of (a) three years following two consecutive quarters of positive earnings before interest, taxes, depreciation and amortization, (b) six years from April 24, 2017, or (c) in the event DPTI fails to raise defined capital amounts or secure defined contract amounts by April 24 in the years 2018, 2019, and 2020. The principal repayment amounts will be due quarterly over a six year period in the amount of CAD$62,500. Based on the exchange rate between the Canadian Dollar and the U.S. Dollar on September 30, 2020, the quarterly principal repayment amounts will be USD$44,271. On May 1, 2020, the Company received an extension for this payment until July 23, 2020. Additionally on July 16, 2020, the Company received a further four month extension until November 2020. The Debenture is secured by the Patents assigned by the University to DPTI by an Assignment Agreement on December 16, 2010. DPTI has pledged the Patents and granted a lien on them pursuant to an escrow agreement dated April 24, 2017, between DPTI and the University. The Debenture was initially recorded at USD$1,491,923 equivalent to CAD$1,500,000 as of December 16, 2010, the date of the original convertible debenture. The liability is being adjusted quarterly based on the current exchange value of the Canadian dollar to the US dollar at the end of each quarter. The adjustment is recorded as unrealized gain or loss in the change of the value of the two currencies during the quarter. The amounts recorded as an unrealized gain (loss) for the three months ended September 30, 2020 and 2019, were ($39,945) and 12,671 respectively. These amounts are included in Accumulated Other Comprehensive Loss in the Equity section of the consolidated balance sheet, and as Unrealized Loss on Foreign Exchange on the consolidated statement of comprehensive loss. The Debenture also includes a provision requiring DPTI to pay the University a two percent (2%) royalty on sales of any and all products or services which incorporate the Patents for a period of five (5) years from April 24, 2018. For the three months ended September 30, 2020, and 2019, the Company recorded interest expense of $12,255 and $12,745, respectively. As of September 30, 2020, the Debenture liability totaled $1,141,494, all of which was long term. Future minimum required payments over the next five years and thereafter are as follows: Period ending September 30, 2021 $ – 2022 – 2023 – 2024 – 2025 and after 1,062,503 Total $ 1,062,503

3. CONVERTIBLE DEBT SECURITIES

3. CONVERTIBLE DEBT SECURITIES	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
CONVERTIBLE DEBT SECURITIES	NOTE 3 – CONVERTIBLE DEBT SECURITIES The Company uses the Black-Scholes Model to calculate the derivative value of its convertible debt. The valuation result generated by this pricing model is necessarily driven by the value of the underlying common stock incorporated into the model. The values of the common stock used were based on the price at the date of issue of the debt security as of September 30, 2020. Management determined the expected volatility between 489.35-582.90%, a risk free rate of interest between 0.12-0.13%, and contractual lives of the debt varying from six months to two years. The table below details the Company's nine outstanding convertible notes, with totals for the face amount, amortization of discount, initial loss, change in the fair market value, and the derivative liability. Face Debt Initial Q3 change Derivative Balance Amount Discount Loss in FMV 9/30/2020 $ 90,228 $ – $ 58,959 $ 65,666 $ 147,000 162,150 – 74,429 106,304 264,566 72,488 – 11,381 (5,738 ) 109,166 201,436 – – (13,300 ) 279,035 76,657 – 8,904 (1,310 ) 106,219 60,115 – 5,651 (10,556 ) 106,405 53,864 – 28,566 (6,472 ) 64,690 25,468 – 16,558 (3,060 ) 30,587 29,250 – – 17,148 28,965 49,726 – – 29,152 49,241 41,774 – – 24,490 41,367 29,250 – – 17,148 28,965 40,000 – 10,605 (4,932 ) 47,835 11,900 – 17,676 (126,690 ) 16,143 Subtotal 944,306 – 232,729 (87,850 ) 1,320,184 Transaction expense – – – – – $ 944,306 $ – $ 232,729 $ (87,850 ) $ 1,320,184 During the three months ended September 30, 2020, a total of $103,257 in principal and $10,754 interest was converted into 1,785,632,186 shares of the Company’s common stock. As of September 30, 2020 and 2019 respectively, there was $944,306 and $928,702 of convertible debt outstanding, net of debt discount of $0, and $93,138, As of September 30, 2020 and 2019 respectively, there was derivative liability of $1,320,184 and $341,209 related to convertible debt securities. The Company recorded interest expense related to the outstanding convertible debt of $21,366 and $22,059 for the three months ended September 30, 2020 and 2019 respectively.

4. STOCKHOLDERS' DEFICIT

4. STOCKHOLDERS' DEFICIT	9 Months Ended
	Sep. 30, 2020
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT	NOTE 4 - STOCKHOLDERS' DEFICIT As of September 30, 2020, there were shares of common stock and 88,235 shares of preferred stock issued and outstanding.

5. COMMITMENTS AND CONTINGENCIE

5. COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 5 - COMMITMENTS & CONTINGENCIES Potential Royalty Payments The Company, in consideration of the terms of the debenture to the University, shall pay to the University a two percent royalty on sales of any and all products or services which incorporate the Company's Patents for a period of five years from April 24, 2018. Legal Matters On March 27, 2019, Thomas A. Cellucci, et al. v. DarkPulse, Inc. et al. (the “Complaint”) was filed in the United States District Court for the Southern District of New York by certain of the Company’s former executive officers, one also being a former director, and a non-employee shareholder (collectively, the “Plaintiffs”), against the Company, its sole officer and director, and others, claiming that the Plaintiffs brought the action to protect their individual rights as minority shareholders, as improperly-ousted officers (other than the non-employee shareholder), and as an improperly-ousted director, seeking equitable relief, damages, recovery of unpaid salaries and other relief. It is the Company's position that the Complaint represents a frivolous harassment lawsuit. The Company has filed a motion to dismiss all claims made in the Complaint and intends to otherwise defend itself vigorously in this matter. The Company is also considering filing counterclaims against the Plaintiffs in the action. From time to time, we may become involved in litigation relating to claims arising out of our operations in the normal course of business. We are not currently involved in any pending legal proceeding or litigation and, to the best of our knowledge, no governmental authority is contemplating any proceeding to which we are a party or to which any of our properties is subject, which would reasonably be likely to have a material adverse effect on our business, financial condition and operating results. COVID-19 On March 11, 2020, the World Health Organization announced that infections of the novel Coronavirus (COVID-19) had become pandemic, and on March 13, the U.S. President announced a National Emergency relating to the disease. There is a possibility of continued widespread infection in the United States and abroad, with the potential for catastrophic impact. National, state and local authorities have required or recommended social distancing and imposed or are considering quarantine and isolation measures on large portions of the population, including mandatory business closures. These measures, while intended to protect human life, are expected to have serious adverse impacts on domestic and foreign economies of uncertain severity and duration. Some economists are predicting the United States will soon enter a recession. The sweeping nature of the coronavirus pandemic makes it extremely difficult to predict how the Company’s business and operations will be affected in the longer run, but we expect that it may materially affect our business, financial condition and results of operations. The extent to which the coronavirus impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others. Moreover, the coronavirus outbreak has begun to have indeterminable adverse effects on general commercial activity and the world economy, and our business and results of operations could be adversely affected to the extent that this coronavirus or any other epidemic harms the global economy generally and/or the markets in which we operate specifically. Any of the foregoing factors, or other cascading effects of the coronavirus pandemic that are not currently foreseeable, could materially increase our costs, negatively impact our revenues and damage the Company’s results of operations and its liquidity position, possibly to a significant degree. The duration of any such impacts cannot be predicted.

6. INTANGIBLE ASSETS

6. INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS	NOTE 6 – INTANGIBLE ASSETS Intangible Assets - Intrusion Detection Intellectual Property The Company relies on patent laws and restrictions on disclosure to protect its intellectual property rights. As of September 30, 2020, the Company held three U.S. and foreign patents on its intrusion detection technology, which expire in calendar years 2025 through 2034 (depending on the payment of maintenance fees). For the three months ended September 30, 2020 and 2019, the Company amortized $12,757, respectively. Future amortization of intangible assets is as follows: 2020 $ 12,757 2021 51,028 2022 51,028 2023 51,028 2024 51,028 Thereafter 189,878 $ 406,747

7. RELATED PARTY TRANSACTIONS

7. RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 7 – RELATED PARTY TRANSACTIONS The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include a) affiliates of the Company; b) Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. In May 2018, the JV Entity received $42,000 for an order from Bravetek and the JV Entity then placed a corresponding order with the Company. The Company’s former executive office is also the CEO of Bravatek. The proceeds were to be used for marketing efforts to generate sales of our intrusion detection product. The order has been recorded as a prepaid sale and is a current liability as of September 30, 2020.

8. PREFERRED STOCK

8. PREFERRED STOCK	9 Months Ended
	Sep. 30, 2020
Stockholders' Equity Note [Abstract]
PREFERRED STOCK	NOTE 8 – PREFERRED STOCK In accordance with the Company’s bylaws, the Company has authorized a total of 2,000,000 shares of preferred stock, par value $0.01 per share, for all classes. As of September 30, 2020 and December 31, 2019, there were 88,235 total preferred shares issued and outstanding for all classes. During the three months ended September 30, 2020, the Company issued no shares of preferred stock .

9. COMMON STOCK

9. COMMON STOCK	9 Months Ended
	Sep. 30, 2020
STOCKHOLDERS' DEFICIT
COMMON STOCK	NOTE 9 – COMMON STOCK In accordance with the Company’s bylaws, the Company has authorized a total of 20,000,000,000 shares of common stock, par value $0.01 per share. As of September 30, 2020 and December 31, 2019, there were 3,394,817,156 and 1,392,042,112 common shares issued and outstanding, respectively. During the three months ended September 30, 2020, the Company issued the following shares of common stock : On July 9, 2020, the Company issued an aggregate of 80,000,000 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $5,600. On July 16, 2020, the Company issued an aggregate of 82,857,143 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $5,800. On July 28, 2020, the Company issued an aggregate of 82,857,143 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $5,800. On August 3, 2020, the Company issued an aggregate of 91,428,571 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $6,400. On August 6, 2020, the Company issued an aggregate of 91,428,571 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $6,400. On August 10, 2020, the Company issued an aggregate of 91,428,571 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $6,400. On August 13, 2020, the Company issued an aggregate of 91,428,571 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $6,400. On August 18, 2020, the Company issued an aggregate of 110,000,000 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $7,700. On August 20, 2020, the Company issued an aggregate of 115,714,286 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $8,100. On August 31, 2020, the Company issued an aggregate of 115,714,286 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $8,100. On September 1, 2020, the Company issued an aggregate of 115,714,286 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $8,100. On September 1, 2020, the Company issued an aggregate of 119,157,924 shares of common stock upon the conversion of interest of convertible debt, as issued on July 17, 2018, in the amount of $6,315. On September 1, 2020, the Company issued an aggregate of 85,000,000 shares of common stock upon the conversion of convertible debt, as issued on September 24, 2018, in the amount of $7,000. On September 2, 2020, the Company issued an aggregate of 123,474,262 shares of common stock upon the conversion of interest of convertible debt, as issued on September 24, 2018, in the amount of $4,439. On September 3, 2020, the Company issued an aggregate of 115,714,286 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $8,100. On September 11, 2020, the Company issued an aggregate of 115,714,286 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $8,100. On September 30, 2020, the Company issued an aggregate of 158,000,000 shares of common stock upon the conversion of convertible debt, as issued on September 25, 2018, in the amount of $5,257.

10. STOCK OPTIONS

10. STOCK OPTIONS	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
STOCK OPTIONS	NOTE 10 – STOCK OPTIONS The Company’s shareholders previously approved, by a majority vote, the adoption of the 1998 Stock Incentive Plan (the “Plan”). As amended on August 11, 2003, the Plan reserves 20,000,000 shares of common stock for issuance upon the exercise of options which may be granted from time-to-time to officers, directors, certain employees and consultants of the Company or its subsidiaries by the Board of Directors. The Plan permits the award of both qualified and non-qualified incentive stock options. During the three months ended September 30, 2020, the Company did not issue any stock options and had no stock options outstanding at September 30, 2020.

11. SUBSEQUENT EVENTS

11. SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 11 – SUBSEQUENT EVENTS The Company evaluated events occurring after the date of the accompanying unaudited condensed consolidated balance sheets through the date the financial statements were issued and has identified the following subsequent events that it believes require disclosure: On October 7, 2020, the Company issued an aggregate of 161,428,571 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $11,800. On October 7, 2020, the Company issued an aggregate of 169,000,000 shares of common stock upon the conversion of convertible debt, as issued on February 12, 2019, in the amount of $6,855. On October 7, 2020, the Company issued an aggregate of 143,519,000 shares of common stock upon the conversion of convertible debt, as issued on September 25, 2018, in the amount of $4,677. On October 12, 2020, the Company issued an aggregate of 142,374,429 shares of common stock upon the conversion of convertible debt, as issued on May 3, 2019, in the amount of $600 in principal and $9,366 in interest. On October 22, 2020, the Company issued an aggregate of 77,623,000 shares of common stock upon the conversion of convertible debt, as issued on September 25, 2018, in the amount of $2,041. On September 2, 2020, the Company entered into a securities purchase agreement with Geneva Roth Remark Holdings, Inc. (“Geneva”) issuing to Geneva a convertible promissory note in the aggregate principal amount of $47,850 (the “Financing”) with a $4,350 original issue discount and $3,500 in transactional expenses due to Geneva and its counsel. The note bears interest at 9% per annum and may be converted into common shares of the Company's common stock at a conversion price equal to 70% of the lowest trading price of the Company's common stock during the 20 prior trading days. The Company received $40,000 net cash in the Financing which closed on October 7, 2020.

1. SIGNIFICANT ACCOUNTING POLIC

1. SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The consolidated financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles of the United States of America (“U.S. GAAP”) and the rules and regulations of the U.S Securities and Exchange Commission for Interim Financial Information. The condensed consolidated financial statements of the Company include the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated. All adjustments (consisting of normal recurring items) necessary to present fairly the Company’s financial position as of September 30, 2020, and the results of operations for three and nine months and cash flows for the nine months ended September 30, 2020 have been included. The results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year.
Description of Business	Description of Business DarkPulse, Inc. ("DPI" or "Company") is a technology-security company incorporated in 1989 as Klever Marketing, Inc. ("Klever"). The Company’s wholly-owned subsidiary, DarkPulse Technologies Inc. ("DPTI"), originally started as a technology spinout from the University of New Brunswick (the “University”) located in Fredericton, Canada. The Company’s security and monitoring systems will initially be delivered in applications for border security, pipelines, the oil and gas industry and mine safety. Current uses of fiber optic distributed sensor technology have been limited to quasi-static, long-term structural health monitoring due to the time required to obtain the data and its poor precision. On April 27, 2018, Klever entered into an Agreement and Plan of Merger (the “Merger Agreement” or the “Merger”) involving Klever as the surviving parent corporation and acquiring a privately held New Brunswick corporation known as DarkPulse Technologies Inc. as its wholly owned subsidiary. On July 18, 2018, the parties closed the Merger Agreement, as amended on July 7, 2018, and the name of the Company was subsequently changed to DarkPulse, Inc. With the change of control of the Company, the Merger was accounted for as a recapitalization in a manner similar to a reverse acquisition. On July 20, 2018, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the State of Delaware, changing the name of the Company to DarkPulse, Inc. The Company filed a corporate action notification with the Financial Industry Regulatory Authority (FINRA), and the Company's ticker symbol was changed to DPLS.
Going Concern Uncertainty	Going Concern Uncertainty As shown in the accompanying financial statements, during the nine months ended September 30, 2020, the Company did not generate any revenues and reported a net loss of $214,539. As of September 30, 2020, the Company’s current liabilities exceeded its current assets by $3,436,901. As of September 30, 2020, the Company had $519 of cash. The Company will require additional funding during the next nine months to finance the growth of its operations and achieve its strategic objectives. These factors, as well as the uncertain conditions that the Company faces relative to capital raising activities, create substantial doubt as to the Company’s ability to continue as a going concern. The Company is seeking to raise additional capital principally through private placement offerings and is targeting strategic partners in an effort to finalize the development of its products and begin generating revenues. The ability of the Company to continue as a going concern is dependent upon the success of future capital offerings or alternative financing arrangements and expansion of its operations. The accompanying financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. Management is actively pursuing additional sources of financing sufficient to generate enough cash flow to fund its operations. However, management cannot make any assurances that such financing will be secured.
Use of Estimates	Use of Estimates In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the statements of financial condition, and revenues and expenses for the years then ended. Actual results may differ significantly from those estimates. Significant estimates made by management include, but are not limited to, the assumptions used to calculate stock-based compensation, derivative liabilities, preferred deemed dividend and common stock issued for services.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with a maturity of three months or less when acquired to be cash equivalents. The Company places its cash with a high credit quality financial institution. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.
Intangible Assets	Intangible Assets The Company reviews intangibles held and used for possible impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In evaluating the fair value and future benefits of its intangible assets, management performs an analysis of the anticipated undiscounted future net cash flow of the individual assets over the remaining amortization period. The Company recognizes an impairment loss if the carrying value of the asset exceeds the expected future cash flows.
Foreign Currrency Translation	Foreign Currency Translation The company translates monetary assets and liabilities (any item paid for or settled in foreign currency) into the United States Dollar at exchange rates prevailing on the balance sheet date. Non-monetary assets and liabilities are translated at the historical rate in effect when the transaction occurred. Revenues and expenses are translated at the spot rate on the date the transaction occurred. Exchange gains and losses from the translation of monetary items are included in unrealized gain/loss on Foreign Exchange as Other Comprehensive Loss. The following table discloses the dates and exchange rates used for converting Canadian Dollar amounts to U.S. Dollar amounts disclosed in the balance sheet and the statement of operations. The spot exchange rate between the Canadian Dollar and the U.S. Dollar on, December 31, 2019 closing rate at 1.2988 US$: CAD, average rate at 1.3234 US$: CAD and for the three months ended September 30, 2020 closing rate at 1.3141 US$: CAD, average rate at 1.3340 US$.
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes, as clarified by ASC 740-10, Accounting for Uncertainty in Income Taxes. Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which the Company operates, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the "more likely than not" criteria of ASC 740. ASC 740-10 requires that the Company recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the "more-likely-than-not" threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.
Accounting for Derivatives	Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, and accruals approximate their fair values because of the short maturity of these instruments. The Company believes the carrying value of its secured debenture payable approximates fair value because the terms were negotiated at arm’s length.
Recent Accounting Pronouncements	Recent Accounting Pronouncements There were no new accounting pronouncements issued or proposed by the Financial Accounting Standards Board during the three months ended September 30, 2020, and through the date of filing of this report that the Company believes has had or will have a material impact on its financial position or results of operations, including the recognition of revenue, cash flow, the merger that was consummated on July 18, 2018. The Company has no lease obligations.
Income (Loss) Per Common Share	Income (Loss) Per Common Share Basic net income (loss) per share of common stock is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share of common stock is computed by dividing net income (loss) by the sum of the weighted average number of common shares outstanding and the dilutive potential common share equivalents outstanding. Potential dilutive common share equivalents consist of shares issuable upon exercise of outstanding convertible preferred stock and stock options. For the three and nine months ended September 30, 2020, there were no stock options nor convertible preferred stock outstanding. For the three and nine months ended September 30, 2020, common stock equivalents related to convertible preferred stock and convertible debt have not been included in the calculation of diluted loss per common share because they are anti-dilutive. Therefore, basic loss per common share is the same as diluted loss per common share. There are 2,138,539,986 common shares reserved for the potential conversion of the Company's convertible debt.

2. DEBENTURE (Tables)

2. DEBENTURE (Tables)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Future minimum required payments	Future minimum required payments over the next five years and thereafter are as follows: Period ending September 30, 2021 $ – 2022 – 2023 – 2024 – 2025 and after 1,062,503 Total $ 1,062,503

3. CONVERTIBLE DEBT SECURITIES

3. CONVERTIBLE DEBT SECURITIES (Tables)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Schedule of convertible debt	The table below details the Company's nine outstanding convertible notes, with totals for the face amount, amortization of discount, initial loss, change in the fair market value, and the derivative liability. Face Debt Initial Q3 change Derivative Balance Amount Discount Loss in FMV 9/30/2020 $ 90,228 $ – $ 58,959 $ 65,666 $ 147,000 162,150 – 74,429 106,304 264,566 72,488 – 11,381 (5,738 ) 109,166 201,436 – – (13,300 ) 279,035 76,657 – 8,904 (1,310 ) 106,219 60,115 – 5,651 (10,556 ) 106,405 53,864 – 28,566 (6,472 ) 64,690 25,468 – 16,558 (3,060 ) 30,587 29,250 – – 17,148 28,965 49,726 – – 29,152 49,241 41,774 – – 24,490 41,367 29,250 – – 17,148 28,965 40,000 – 10,605 (4,932 ) 47,835 11,900 – 17,676 (126,690 ) 16,143 Subtotal 944,306 – 232,729 (87,850 ) 1,320,184 Transaction expense – – – – – $ 944,306 $ – $ 232,729 $ (87,850 ) $ 1,320,184

6. INTANGIBLE ASSETS (Tables)

6. INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of future amortization expense	For the three months ended September 30, 2020 and 2019, the Company amortized $12,757, respectively. Future amortization of intangible assets is as follows: 2020 $ 12,757 2021 51,028 2022 51,028 2023 51,028 2024 51,028 Thereafter 189,878 $ 406,747

1. BASIS OF FINANCIAL STATEME_2

1. BASIS OF FINANCIAL STATEMENTS AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)shares	Sep. 30, 2019USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Net loss	$ (174,022)	$ 21,866	$ (388,561)	$ (659,473)
Working capital	(3,436,901)		(3,436,901)
Cash	$ 519	$ 1,408	$ 519	$ 1,408	$ 1,210	$ 72,294
Antidilutive shares outstanding | shares			2,138,539,986
C A D
Foreign currency translation rates	1.3141		1.3141		1.2988
Foreign currency translation rates during the period	1.3340				1.3234

2. DEBENTURE (Details)

2. DEBENTURE (Details)	Sep. 30, 2020USD ($)
Debt Disclosure [Abstract]
Period ending 2021	$ 0
Period ending 2022	0
Period ending 2023	0
Period ending 2024	0
Period ending 2025 and after	1,062,503
Total	$ 1,062,503

2. DEBENTURE (Details Narrative

2. DEBENTURE (Details Narrative) - USD ($)	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Unrealized gain (loss) on derivatives	$ (39,945)	$ 12,671
Interest expense	12,255	$ 12,745
Debenture liability	$ 1,141,494		$ 1,155,150

3. CONVERTIBLE DEBT SECURITIE_2

3. CONVERTIBLE DEBT SECURITIES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Amortization of discount			$ 39,414	$ 568,985
Change in Fair Market Value	$ (87,852)	$ 221,879	(44,684)	$ 566,127
Derivative balance	1,320,184		1,320,184		$ 1,275,500
Convertible Debt 1 [Member]
Face amount	90,228		90,228
Amortization of discount			0
Initial loss			58,959
Change in Fair Market Value			65,666
Derivative balance	147,000		147,000
Convertible Debt 2 [Member]
Face amount	162,150		162,150
Amortization of discount			0
Initial loss			74,429
Change in Fair Market Value			106,304
Derivative balance	264,566		264,566
Convertible Debt 3 [Member]
Face amount	72,488		72,488
Amortization of discount			0
Initial loss			11,381
Change in Fair Market Value			(5,738)
Derivative balance	109,166		109,166
Convertible Debt 4 [Member]
Face amount	201,436		201,436
Amortization of discount			0
Initial loss			0
Change in Fair Market Value			(13,300)
Derivative balance	279,035		279,035
Convertible Debt 5 [Member]
Face amount	76,657		76,657
Amortization of discount			0
Initial loss			8,904
Change in Fair Market Value			(1,310)
Derivative balance	106,219		106,219
Convertible Debt 6 [Member]
Face amount	60,115		60,115
Amortization of discount			0
Initial loss			5,651
Change in Fair Market Value			(10,556)
Derivative balance	106,405		106,405
Convertible Debt 7 [Member]
Face amount	53,864		53,864
Amortization of discount			0
Initial loss			28,566
Change in Fair Market Value			(6,472)
Derivative balance	64,690		64,690
Convertible Debt 8 [Member]
Face amount	25,468		25,468
Amortization of discount			0
Initial loss			16,558
Change in Fair Market Value			(3,060)
Derivative balance	30,587		30,587
Convertible Debt 9 [Member]
Face amount	29,250		29,250
Amortization of discount			0
Initial loss			0
Change in Fair Market Value			17,148
Derivative balance	28,965		28,965
Convertible Debt 10 [Member]
Face amount	49,726		49,726
Amortization of discount			0
Initial loss			0
Change in Fair Market Value			29,152
Derivative balance	49,241		49,241
Convertible Debt 11 [Member]
Face amount	41,774		41,774
Amortization of discount			0
Initial loss			0
Change in Fair Market Value			24,490
Derivative balance	41,367		41,367
Convertible Debt 12 [Member]
Face amount	29,250		29,250
Amortization of discount			0
Initial loss			0
Change in Fair Market Value			17,148
Derivative balance	28,965		28,965
Convertible Debt 13 [Member]
Face amount	40,000		40,000
Amortization of discount			0
Initial loss			10,605
Change in Fair Market Value			(4,932)
Derivative balance	47,835		47,835
Convertible Debt 14 [Member]
Face amount	11,900		11,900
Amortization of discount			0
Initial loss			17,676
Change in Fair Market Value			(126,690)
Derivative balance	16,143		16,143
Derivative Liabilities [Member]
Face amount	944,306		944,306
Amortization of discount			0
Initial loss			232,729
Change in Fair Market Value			(87,850)
Transaction expense			0
Derivative balance	$ 1,320,184		$ 1,320,184

3. CONVERTIBLE DEBT SECURITIE_3

3. CONVERTIBLE DEBT SECURITIES (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Debt Disclosure [Abstract]
Convertible debt outstanding	$ 944,306	$ 928,702
Unamortized debt discount	0	93,138
Derivative liability	1,320,184	341,209
Interest expense	$ 21,366	$ 22,059

6. INTANGIBLE ASSETS (Details)

6. INTANGIBLE ASSETS (Details)	Sep. 30, 2020USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Future amortization 2020	$ 12,757
Future amortization 2021	51,028
Future amortization 2022	51,028
Future amortization 2023	51,028
Future amortization 2024	51,028
Thereafter	189,878
Total future amortization	$ 406,747

6. INTANGIBLE ASSETS (Details N

6. INTANGIBLE ASSETS (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangibles	$ 12,757	$ 12,757	$ 38,271	$ 38,271

7. RELATED PARTY TRANSACTIONS (

7. RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2018	Sep. 30, 2020	Dec. 31, 2019
Contract liability, related party		$ 42,000	$ 42,000
Bravetek and JV Entity [Member]
Advance from related party	$ 42,000
Contract liability, related party		$ 42,000

9. COMMON STOCK (Details Narrat

9. COMMON STOCK (Details Narrative) - Conversion of Convertible Debt [Member] - USD ($)	6 Months Ended	7 Months Ended						8 Months Ended							9 Months Ended
	Jul. 09, 2020	Aug. 13, 2020	Aug. 10, 2020	Aug. 06, 2020	Aug. 03, 2020	Jul. 28, 2020	Jul. 16, 2020	Sep. 11, 2020	Sep. 03, 2020	Sep. 02, 2020	Sep. 01, 2020	Aug. 31, 2020	Aug. 20, 2020	Aug. 18, 2020	Sep. 30, 2020
Debt converted, stock issued	80,000,000	91,428,571	91,428,571	91,428,571	91,428,571	82,857,143	82,857,143	115,714,286	115,714,286	123,474,262	115,714,286	115,714,286	115,714,286	110,000,000	158,000,000
Debt converted, stock value	$ 5,600	$ 6,400	$ 6,400	$ 6,400	$ 6,400	$ 5,800	$ 5,800	$ 8,100	$ 8,100	$ 4,439	$ 8,100	$ 8,100	$ 8,100	$ 7,700	$ 5,257
Debt converted, stock issued											119,157,924
Debt converted, stock value											$ 6,315
Debt converted, stock issued											85,000,000
Debt converted, stock value											$ 7,000

10. STOCK OPTIONS (Details Narr

10. STOCK OPTIONS (Details Narrative)	9 Months Ended
	Sep. 30, 2020shares
Share-based Payment Arrangement [Abstract]
Common stock reserved for issuance	20,000,000
Stock options granted	0